Deep learning using contrast-enhanced ultrasound images to predict the nuclear grade of clear cell renal cell carcinoma
View abstract on PubMed
Summary
This summary is machine-generated.A deep learning model effectively distinguishes high-grade from low-grade clear cell renal cell carcinoma (ccRCC) using contrast-enhanced ultrasound (CEUS) images. This non-invasive AI approach shows promise for accurate ccRCC grading.
Area Of Science
- Medical Imaging
- Artificial Intelligence in Oncology
- Renal Cell Carcinoma Research
Background
- Clear cell renal cell carcinoma (ccRCC) grading is crucial for treatment decisions.
- Distinguishing low-grade from high-grade ccRCC non-invasively remains a clinical challenge.
- Contrast-enhanced ultrasound (CEUS) offers a dynamic imaging modality for renal tumor assessment.
Purpose Of The Study
- To evaluate a deep learning (DL) model's efficacy in differentiating low-grade (I-II) from high-grade (III-IV) ccRCC.
- To assess the performance of CEUS-based AI in ccRCC classification.
- To validate the non-invasive grading capability of the proposed DL model.
Main Methods
- Retrospective analysis of 177 Fuhrman-graded ccRCC cases using CEUS images.
- Development of a RepVGG-based deep learning model for ccRCC grade classification.
- Performance evaluation using sensitivity, specificity, accuracy, and AUC; Class Activation Mapping (CAM) for interpretability.
Main Results
- The DL model achieved 74.8% sensitivity, 79.1% specificity, and 77.0% accuracy in the test set.
- Area Under the Curve (AUC) reached 0.852, indicating strong discriminative power.
- CAM visualization highlighted specific image regions contributing to the model's high-grade ccRCC predictions.
Conclusions
- Deep learning models utilizing CEUS images can accurately differentiate low-grade from high-grade ccRCC.
- The proposed AI approach offers a non-invasive method for ccRCC grading.
- CEUS combined with DL shows potential for improving ccRCC management and treatment planning.

